Both in Pharmaceuticals
Propanc Biopharma vs Karyopharm Therapeutics
Over the past year PPCB returned −99.3% and KPTI returned −98.7%; their daily moves had a correlation of -0.00.
PPCB −99.3% KPTI −98.7%Growth of $1, one year, split-adjusted
| Metric | PPCB | KPTI |
|---|---|---|
| Price | $1.79 | $0.0729 |
| Market cap | $1.8M | $1.7M |
| Today | +4.68% | −17.44% |
| 1 month | −63.6% | −88.8% |
| 6 months | −92.9% | −99.2% |
| Year to date | −98.7% | −99.0% |
| 1 year | −99.4% | −98.8% |
| Revenue growth (YoY) | — | −11.9% |
| Gross margin | — | 96.8% |
| Net margin | — | −200.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.0× |
| Net cash | $832.0K | -$184.8M |
| Dividend yield | — | — |
| Volatility (60d) | 730.0% | 413.8% |
| Short % of float | 0.7% | 34.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).